MICROALBUMINURIA
Clinical trials for MICROALBUMINURIA explained in plain language.
Never miss a new study
Get alerted when new MICROALBUMINURIA trials appear
Sign up with your email to follow new studies for MICROALBUMINURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral peptide therapy aims to protect kidneys in chronic disease
Disease control Recruiting nowThis study tests a liquid medication called ACE Reno, taken under the tongue four times a day for 12 weeks, in 300 adults with kidney damage from diabetes, high blood pressure, autoimmune diseases, or other causes. The goal is to see if it can reduce protein in the urine and help…
Matched conditions: MICROALBUMINURIA
Phase: PHASE4 • Sponsor: Ace Cells Lab Limited • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
AI health app aims to tame the 'Three Highs' in massive new taipei trial
Disease control Recruiting nowThis large study will test if a mobile health platform with digital tools helps people better manage high blood pressure, blood sugar, and cholesterol. Over 4,000 adults in New Taipei City will use the platform to track their numbers and get guidance. The goal is to see if this a…
Matched conditions: MICROALBUMINURIA
Phase: NA • Sponsor: New Taipei City Medical Association • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC